09 November 2022
Russia is planning to develop a system of medical care to patients with hepatitis C and improve the mechanisms for funding such treatment on the basis of compulsory medical insurance (CHI). This is provided for in the action plan to combat the disease. The document was approved by Government Decree No. 3306-r dated November 2, 2022.
The plan is set to run until 2030, but most of the work will begin now.
Earlier, GxP News reported that Tatyana Golikova instructed the Ministry of Health, the Ministry of Industry and Trade, Rospotrebnadzor, Rosstandart, and the compulsory medical insurance fund (FOMS) to consider the plan prepared by the Central Office of the Government of the Russian Federation by September 10.
PrintRussia’s government will allow import of unregistered biomedical cellular products
08 February 2023
08 February 2023
RNC Pharma presented an analysis of drug production in Russia for year 2022
07 February 2023
Layoffs continue to batter biotech, with Big Pharmas piling on the pain
07 February 2023